Skip to Main Content
May 15, 2024

Holland & Hart Represents In-House Health in $4M Series Seed Financing

Holland & Hart represented In-House Health, Inc., the developer of an AI-driven scheduling and management platform for nursing teams, in connection with the closing of its $4 million Series Seed financing. The investors included New Enterprise Associates, Trail Mix Ventures, Vine Ventures, and Longevity Venture Partners.

In-House Health works with hospitals and providers to streamline staffing workflows. In-House’s AI algorithm is trained on millions of patient records to identify patterns of bedside care and anticipate shift changes weeks earlier than is normally possible. As a result, the algorithm can shorten hours spent on scheduling by half or more and reduce labor costs by over 10%, amid the growing workforce shortage and spiraling costs to deliver care.

For more information, please see In-House Health’s press release.

The Holland & Hart transactional team was led by corporate partner Byron Crowe and included Andrew Leddy and Tim Percival.

Holland & Hart’s Corporate group works closely with companies throughout their lifecycles to provide swift, strategic counsel. From day-to-day business operations to major transactions, Holland & Hart attorneys guide companies of all sizes through the complex regulatory, commercial, financial, and governance matters critical to a thriving enterprise.


Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.